HIV vaccines guide rare immune cells to make broadly neutralizing antibodies
Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.
Three studies in non-human primates show that strategically designed vaccines could prime a population of B cells to produce effective antibodies against HIV.
About this story
This story was aggregated from Nature. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.
Read the full story →For agents:JSON recordOpenAPIWebMCPllms.txt